masoprocol has been researched along with Fatty Liver in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azhar, S; Bittner, A; Bittner, S; Cortez, Y; Hou, X; Hu, J; Kraemer, FB; Li, Y; Shen, WJ; Singh, M; Tabassum, J; Zhang, H | 1 |
| Hwang, JK; Jo, K; Kim, D; Lee, MS | 1 |
| Azhar, S; Cortez, Y; Kraemer, FB; Shen, WJ; Zhang, H | 1 |
| Denda, A; Endoh, T; Horiguchi, K; Kobayashi, E; Konishi, Y; Nakae, D; Noguchi, O; Ogasawara, H; Sugimura, M; Tamura, K; Tang, Q; Tsujiuchi, T | 1 |
4 other study(ies) available for masoprocol and Fatty Liver
| Article | Year |
|---|---|
Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Blotting, Western; Fatty Acid-Binding Proteins; Fatty Liver; Fructose; Gene Expression Regulation; Hypertriglyceridemia; Larrea; Lipid Metabolism; Lipogenesis; Liver; Male; Masoprocol; PPAR alpha; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1 | 2015 |
Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
Topics: Adiposity; AMP-Activated Protein Kinases; Animals; Diet; Dietary Fats; Fatty Liver; Hepatocytes; Insulin; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Triglycerides; Weight Gain | 2010 |
Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARĪ±-dependent and -independent pathways.
Topics: Adipokines; Animals; Diet; Endoplasmic Reticulum Stress; Endoribonucleases; Fatty Acids; Fatty Liver; Glucose Tolerance Test; Hypolipidemic Agents; Leptin; Lipid Metabolism; Lipid Metabolism Disorders; Lipoproteins, VLDL; Lipoxygenase Inhibitors; Liver; Male; Masoprocol; Mice; Mice, Inbred C57BL; Mice, Knockout; Microarray Analysis; Multigene Family; PPAR alpha; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Signal Transduction; Triglycerides | 2013 |
Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.
Topics: Acetophenones; Animals; Aspirin; Choline; Choline Deficiency; Cyclooxygenase Inhibitors; Fatty Liver; gamma-Glutamyltransferase; Glutathione Transferase; Lipoxygenase Inhibitors; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Masoprocol; Methionine; Oxidative Stress; Phospholipases A; Phospholipases A2; Precancerous Conditions; Quercetin; Rats; Rats, Inbred F344; Time Factors | 1996 |